12:00 AM
Jun 04, 2012
 |  BC Week In Review  |  Company News  |  Deals

Altacor, Nicox deal

NicOx said its board of directors unanimously decided not to exercise an option to acquire the 88.2% of ophthalmic company...

Read the full 78 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >